Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMolecular ImagingPET reveals brain receptor deficits in schizophreniaThe study confirms that deficits in M1 receptor are present in a subgroup of schizophrenia patients.MRIMRI finds perfusion defects across a range of lung impairmentsCTAI detects lung cancer nodules well but shows low specificityMolecular ImagingRadiopharmaceutical manufacturers report uneven FDA inspectionsSponsor ContentAI for CT & PET/CT Imaging
